Topical Skin Protectants

Key Points

• Topical skin protectants create a physical barrier between the skin and moisture, urine, stool, or wound exudate — preventing skin breakdown (maceration, excoriation, and moisture-associated skin damage).
• Zinc oxide is a classic skin protectant — used in diaper rash products and incontinence care; soothes, reduces inflammation, and forms a protective layer.
• Moisture barrier ointments (petrolatum, dimethicone-based) are core interventions for patients at risk of incontinence-associated dermatitis (IAD) — applied after each incontinence episode.
• Calamine lotion (zinc oxide + ferric oxide) soothes contact dermatitis, reduces itching and burning from skin irritants.
• Skin protectants are not therapeutic treatments for active infections or pressure injuries — they are preventive and protective agents used to maintain skin integrity.

Mechanism of Action

Topical skin protectants work by creating a physical occlusive barrier on the skin surface:

1. Barrier formation: The protectant coats the skin, preventing contact between irritants (urine, stool, wound exudate, moisture) and the epidermal layer
2. Reduction of friction: Occlusive properties reduce friction between skin and surfaces (linens, clothing)
3. Moisture regulation: Some formulations retain skin moisture (emollient effect) while preventing external moisture penetration
4. Anti-inflammatory effect (zinc oxide): Mild anti-inflammatory action soothes irritated skin

Common Topical Skin Protectant Agents

Zinc Oxide

Mechanism: Creates a physical barrier; has mild astringent and antiseptic properties; reduces itching and burning at the application site.

Forms: Ointment (40% zinc oxide), paste, calamine lotion (zinc oxide + ferric oxide)

Clinical applications:

• Diaper rash and neonatal skin protection
• Incontinence-associated dermatitis (IAD) prevention — applied after perineal cleansing
• Pressure injury prevention — periwound skin protection
• Contact dermatitis — calamine lotion soothes irritant contact dermatitis

Nursing considerations:

• Apply liberally to clean, dry skin — do not rub into skin; pat on gently
• Do not remove zinc oxide with each diaper change — remove accumulated product only at bath time to avoid skin trauma
• Zinc oxide is thick and difficult to remove; use petroleum jelly or a gentle cleanser if removal is necessary

Petrolatum (White Petroleum Jelly)

Mechanism: Occlusive agent — creates a waterproof physical barrier; prevents transepidermal water loss.

Clinical applications:

• Moisture retention on dry, intact skin
• Protection of periwound skin from wound exudate
• Lip and skin protection in post-procedure care

Dimethicone-Based Barrier Products

Mechanism: Silicone-based polymer that coats skin surface; not absorbed into skin; repels water and body fluids.

Clinical applications:

• Incontinence care products (barrier films, wipes, creams)
• Preferred over petroleum-based products for patients with absorption concerns or skin folds
• Allows breathability while maintaining barrier protection

Calamine Lotion (Zinc Oxide + Ferric Oxide)

Mechanism: Zinc oxide provides barrier and anti-inflammatory effects; ferric oxide provides mild astringent properties and the characteristic pink color.

Clinical applications:

• Contact dermatitis from irritants (poison ivy/oak, soaps, cosmetics, jewelry)
• Reduces itching and burning
• Promotes comfort while skin heals

Clinical Applications by Condition

Incontinence-Associated Dermatitis (IAD)

IAD vs. Pressure Injury

IAD (moisture-associated skin damage) must be distinguished from pressure injuries. Stage 1 and 2 pressure injuries may resemble IAD but have different etiology. Moisture barrier protectants treat and prevent IAD; pressure redistribution addresses pressure injuries.

IAD Prevention Protocol:

1. Cleanse perineal skin with gentle pH-balanced cleanser after each incontinence episode
2. Pat dry — avoid rubbing
3. Apply moisture barrier ointment (zinc oxide or dimethicone-based) immediately after cleansing
4. Check incontinence pads frequently (every 2–3 hours)

Pressure Injury Prevention

Role of skin protectants:

• Protect intact periwound skin from maceration from wound exudate
• Applied to skin around wound dressings as secondary protection
• Used on skin folds and sacrum in incontinent patients at risk for pressure injury

Contact Dermatitis

• Apply calamine lotion or zinc oxide to soothe inflamed skin
• Hydrocortisone cream (corticosteroid) may be used alongside for anti-inflammatory effect
• Identify and remove the causative irritant/allergen

Nursing Assessment

NCLEX Focus

Skin protectants are a core nursing intervention for incontinence-associated dermatitis prevention. The priority nursing action for incontinence-related skin breakdown is consistent perineal care + moisture barrier application. Distinguish between IAD (erythema/erosion without deep tissue involvement) and pressure injuries (staged by depth).

• Assess skin integrity at each care interaction — color, turgor, moisture, breakdown
• Assess incontinence frequency and type (urine vs. fecal — fecal more damaging)
• Assess Braden Scale moisture subscale to guide frequency of moisture barrier application
• Assess allergies to specific skin care products (lanolin, fragrances, preservatives)

Nursing Interventions

• Apply moisture barrier ointment after every incontinence episode to clean, dry skin
• Use moisture barrier ointments (not thick creams) for patients with frequent liquid stool — barriers are more protective
• Educate caregivers: apply protectant liberally without rubbing; cover all at-risk skin in perigenital area
• For patients on low air loss beds (highest pressure injury risk): use moisture-wicking products and maintain consistent protectant application
• Document skin condition at least every shift for at-risk patients

Related Concepts

• pressure-injury-staging-and-risk-assessment — Moisture barrier application is a key intervention in Braden Scale-guided pressure injury prevention.
• integumentary-system — Understanding intact skin function supports rationale for barrier protection.
• delayed-wound-healing-factors-and-complications — Maceration from moisture impairs wound healing; protectants prevent periwound skin breakdown.
• hygiene-factors-and-person-centered-planning — Skin care and incontinence management are core components of hygiene care planning.
• fecal-incontinence-and-bowel-retraining — Fecal incontinence is a major cause of IAD; protectants are used alongside bowel management strategies.

Self-Check

1. A patient with urinary incontinence has Stage 1 perigenital erythema. What is the priority nursing intervention?
2. What is the difference between incontinence-associated dermatitis (IAD) and a Stage 1 pressure injury, and how does the nursing intervention differ?
3. A nurse is applying zinc oxide to a patient’s perigenital skin after incontinence. How should the product be applied, and how often should it be reapplied?